Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Computer-Aided Drug Design Boosts RAS Inhibitor Discovery
Ge Wang, Yuhao Bai, Jiarui Cui, et al.
Molecules (2022) Vol. 27, Iss. 17, pp. 5710-5710
Open Access | Times Cited: 14

Showing 14 citing articles:

Dynamic regulation of RAS and RAS signaling
Walter Kölch, Dénes Berta, Edina Rosta
Biochemical Journal (2023) Vol. 480, Iss. 1, pp. 1-23
Open Access | Times Cited: 50
Exploring Small-Molecule Inhibitors Targeting MAPK Pathway Components: Focus on ERK, MEK1, and MEK2 Kinases in Cancer Treatment
Tuhin Mukherjee, Satyajit Mohanty, Jasleen Kaur, et al.
Chemical Biology Letters (2024) Vol. 11, Iss. 2, pp. 659-659
Open Access | Times Cited: 5
An in-depth review of AI-powered advancements in cancer drug discovery
Le Huu Nhat Minh, P Nguyen, Nguyen Thi Trang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167680-167680
Closed Access
Computational Exploration of Licorice for Lead Compounds against Plasmodium vivax Duffy Binding Protein Utilizing Molecular Docking and Molecular Dynamic Simulation
Muhammad Yasir, Jinyoung Park, Eun‐Taek Han, et al.
Molecules (2023) Vol. 28, Iss. 8, pp. 3358-3358
Open Access | Times Cited: 8
A comprehensive review of new small molecule drugs approved by the FDA in 2022: Advance and prospect
Yi‐Ru Bai, Xin Yang, Ken Chen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116759-116759
Closed Access | Times Cited: 2
Benchmarking different docking protocols for predicting the binding poses of ligands complexed with cyclooxygenase enzymes and screening chemical libraries
Sara Shamsian, Babak Sokouti, Siavoush Dastmalchi
Bioimpacts (2023) Vol. 14, pp. 29955-29955
Open Access | Times Cited: 7
Navigating the complexity of p53-DNA binding: implications for cancer therapy
Kelly M. Thayer, Sean Stetson, Fernando Caballero, et al.
Biophysical Reviews (2024)
Open Access | Times Cited: 1
Molecular dynamics simulations for the structure-based drug design: targeting small-GTPases proteins
Angela Parise, Sofia Cresca, Alessandra Magistrato
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 10, pp. 1259-1279
Closed Access | Times Cited: 1
Computational biology-based study of the molecular mechanism of spermidine amelioration of acute pancreatitis
Yan Shen, Hongtao Duan, Lu Yuan, et al.
Molecular Diversity (2023) Vol. 28, Iss. 4, pp. 2583-2601
Closed Access | Times Cited: 4
Development of Masitinib Derivatives with Enhanced Mpro Ligand Efficiency and Reduced Cytotoxicity
Cintia A. Menéndez, Adil Mohamed, Gustavo R. Pérez-Lemus, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6643-6643
Open Access | Times Cited: 2
Revolutionizing Medicine
Ranjit Barua
Advances in medical technologies and clinical practice book series (2024), pp. 365-392
Closed Access
Molecular Dynamics in Computer-Aided Drug Discovery: Unveiling Insights into Biomolecular Interactions
Manos C. Vlasiou
BENTHAM SCIENCE PUBLISHERS eBooks (2024), pp. 17-47
Closed Access
Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis
Kang Zheng, Fengjie Hao, Sandra Medrano-Garcia, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 8
Open Access | Times Cited: 1
Artificial Intelligence-Mediated Computer-Aided Design of Viral Gene Therapies
Alireza Daneshvar, Stefan Lukianov
GEN Biotechnology (2023) Vol. 2, Iss. 6, pp. 482-489
Closed Access | Times Cited: 1
Page 1

Scroll to top